« Return to News | Miscellaneous

Premier Research Group Acquires Two More CROs

Friday, July 13, 2007 09:32 AM

London-based contract research organization (CRO) Premier Research Group continued its acquisition spree by purchasing two more CROs. Premier Research bought ARS Inc., based in Boston, and D-TARGET SA, located in Switzerland. Premier has acquired six CROs since 2004 when it went public.

Premier expects ARS will strengthen its presence in the New England biotech market while D-Target's medical device focus will bring expanded expertise in that area to customers in both the United States and Europe. ARS also has expertise in Oracle Clinical.

The acquisition of the two companies continues the Premier’s strategy of building an international business both organically and through strategic acquisitions.

Dr. Simon Yaxley, chief executive officer of Premier Research, said, "Both firms clearly represent a further important step in our strategy of building a leading international contract research organization."

Yaxley added that both companies have strong order books. "Both also offer a number of complementary synergies to the enlarged Group and further strengthen Premier Research's position in the international CRO market," he said.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.